NCT00121823View on ClinicalTrials.gov

Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

December 31, 2004

Conditions
Malaria
Interventions
BIOLOGICAL

FP9 ME-TRAP

BIOLOGICAL

MVA ME-TRAP

Trial Locations (1)

P.O.Box 273, Banjul

Medical Research Council Laboratories, Banjul

All Listed Sponsors
collaborator

Medical Research Council Unit, The Gambia

OTHER

collaborator

University of Oxford

OTHER

collaborator

Wellcome Trust

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT00121823 - Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines | Biotech Hunter | Biotech Hunter